{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidqc3vd5dv53udoi6fn63bu2abtpoxfwiuo3wzkeygdw2geycjxhe",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mjufgesr2wi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigsj46xssk5tx5pgwhed7tfozd4ppguct7nlgeh2vzm4o5ierjigm"
    },
    "mimeType": "image/jpeg",
    "size": 1508
  },
  "path": "/story/387293/peptides-are-booming-in-a-medical-gray-zone.html",
  "publishedAt": "2026-04-19T09:25:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "People are lining up—and in some cases paying five figures a year—to inject substances the FDA hasn't signed off on. In the New Yorker , physician-writer Dhruv Khullar digs into the booming world of peptides: short amino-acid chains sold as everything from injury repair tools to longevity hacks. The...",
  "title": "Peptides Are Booming— in a Medical Gray Zone"
}